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Abstract
TROP2, a cell surface protein structurally related to EpCAM, is expressed in various carcinomas, though its function remains
largely unknown. We examined the expression of TROP2 and EpCAM in fetal mouse tissues, and found distinct patterns in
the ureteric bud of the fetal kidney, which forms a tree-like structure. The tip cells in the ureteric bud proliferate to form
branches, whereas the trunk cells differentiate to form a polarized ductal structure. EpCAM was expressed throughout the
ureteric bud, whereas TROP2 expression was strongest at the trunk but diminished towards the tips, indicating the distinct
cell populations in the ureteric bud. The cells highly expressing TROP2 (TROP2
high) were negative for Ki67, a proliferating cell
marker, and TROP2 and collagen-I were co-localized to the basal membrane of the trunk cells. TROP2
high cells isolated from
the fetal kidney failed to attach and spread on collagen-coated plates. Using MDCK cells, a well-established model for
studying the branching morphogenesis of the ureteric bud, TROP2 was shown to inhibit cell spreading and motility on
collagen-coated plates, and also branching in collagen-gel cultures, which mimic the ureteric bud’s microenvironment.
These results together suggest that TROP2 modulates the interaction between the cells and matrix and regulates the
formation of the ureteric duct by suppressing branching from the trunk during kidney development.
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Introduction
TROP2, also known as EGP-1, M1S1, GA733-1, and
TACSTD2, is a 36-kDa membrane glycoprotein, initially identified
as a tumor-associated calcium signal transducer (TACSTD)
expressed in gastrointestinal, bladder, lung, and cervix carcinomas
and later found to be highly expressed in many other tumors
including pancreatic cancers and squamous cell carcinomas of the
oral cavity [1]. TROP2 is strongly expressed in trophoblasts
forming the outer layer of the blastocyst which develops into the
placenta [2]. In the prostate, TROP2 is specifically expressed in
prostate stem cells located in the basal region [3]. We have recently
found that TROP2 is expressed in hepaticprogenitor cells known as
oval cells, which are produced in response to severe liver injury and
form duct-like structures surrounding the portal vein [4].
TROP2 is structurally related to epithelial cell adhesion
molecule (EpCAM), also known as TACSTD1. Both TROP2
and EpCAM are type I transmembrane proteins, consisting of a
hydrophobic leader peptide, a thyroglobulin-like domain, a single
transmembrane domain and a short cytoplasmic domain. The
cytoplasmic tail of TROP2, but not EpCAM, contains a region
homologous to phosphatidylinositol 4,5-bisphosphate (PIP2)-bind-
ing motif [5]. EpCAM is widely expressed in epithelial cells and
plays roles in cell-cell adhesion, cell proliferation and cell motility
[6–10]. On the other hand, TROP2 was suggested to enhance the
proliferation of tumor cells in an anchorage-independent manner
[11] and the formation of tight junctions by interacting with
Claudin-1 and -7 in the corneal epithelium [12]. However,
TROP2 expression in normal tissues and its functions still remain
largely unstudied.
In the development of the mammalian kidney, the ureteric bud
epithelium proliferates and branches to form a tree-like structure
[13,14]. This process is known as branching morphogenesis and
depends on interactions of the ureteric bud with the metanephric
mesenchyme and also components of the extracellular matrix
(ECM). Factors secreted from the metanephric mesenchyme
enhance the proliferation, elongation and branching of the
ureteric bud cells, resulting in differentiation to form the collecting
duct system. On the other hand, ECM components around the
ureteric bud modulate growth factor signaling and provide an
anchorage for cell migration via the ECM-specific integrin
receptors on the ureteric bud cells [15,16].
The cells forming the tip and trunk of the ureteric bud exhibit
different characteristics [17]. The tip cells are proliferating
immature cells that are located at the branching points and
interact with the metanephric mesenchyme. By contrast, the trunk
cells are differentiating into the collecting duct with a rigid
structure consisting of polarized epithelial cells. While the
molecular mechanisms underlying the establishment of the tip
structure have been well studied, little is known about the
mechanisms of trunk morphogenesis. In particular, the factors
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unknown.
To gain insights into the functions of TROP2, we examined the
expression of TROP2 together with EpCAM during mouse
development and found that the two differ significantly. During
development, EpCAM was widely expressed in epithelial tissues,
whereas TROP2 expression was restricted to EpCAM
+ cells in a
few organs. In particular, a unique pattern of TROP2 expression
was found in fetal kidney, i.e., TROP2 expression increases from
the tip toward the trunk of the ureteric bud, whereas EpCAM was
expressed uniformly. In this study, we show that the expression
pattern does not appear to correlate with the known functions of
TROP2 in cell proliferation and tight junction formation. Using
anti-TROP2 and anti-EpCAM antibodies (Abs), we isolated the
tip cells and trunk cells of the ureteric buds, and revealed that their
morphology on collagen-gel differs significantly, i.e. tip cells
spread, whereas trunk cells remain a rounded shape. We further
demonstrate that TROP2 alters cell shape and motility on
collagen-gel using a primary culture of ureteric bud cells and that
it also inhibits branching of MDCK cells. Our findings suggest that
TROP2 plays a role in the development of a ductal structure of
ureteric trunks by suppressing the formation of new branches.
Results
Expression of TROP2 during kidney development
We performed an immunohistochemical analysis of mouse
embryos by using anti-EpCAM and anti-TROP2 Abs. At
embryonic day 14.5 (E14.5), EpCAM was expressed in a variety
of epithelial tissues including lung, gut, kidney, pancreas and
epidermis. By contrast, TROP2 expression was restricted to a few
tissues including kidney, gut and epidermis, and the TROP2
+ cells
were a subpopulation of EpCAM
+ cells (Fig. 1A–C). Because
TROP2 was highly expressed in the kidney, we focused on the
expression and role of TROP2 in kidney development.
In mice, the ureteric bud emerges at E10.5 from the Wolffian
duct, which is induced by GDNF from metanephric mesenchyme
[18,19]. Subsequently, the ureteric buds are also induced to form
the first branch at E11.5 and undergo further branching until
E14.5,15.0 by the signals from metanephric mesenchyme.
Immunostaining in the fetal kidney at E11.5 revealed that
EpCAM was uniformly expressed in the ureteric bud and the
Wolffian duct (Figure 2A, arrow and arrowhead, respectively)
[20]. Interestingly, TROP2 was expressed at the trunk of the
ureteric bud and the Wolffian duct, but its expression was weak at
the tip of the ureteric bud that is surrounded by metanephric
mesenchyme (Figure 2A, yellow arrowhead). At E14.5, although
EpCAM was expressed uniformly throughout the ureteric buds,
TROP2 was expressed at the trunk but barely detectable at the tip
(Figure 2B, yellow arrowhead). This gradient of TROP2
expression at the ureteric bud suggests TROP2 to be involved in
morphogenesis of the ureteric bud, especially in the trunk.
Characterization of TROP2
+ and EpCAM
+ cells in fetal
kidney
To characterize the cells expressing TROP2 in the ureteric bud,
we performed a flow cytometric analysis and revealed that
EpCAM
+ cells in E12.5 kidney were divided into at least 2
populations, TROP2
+ and TROP2
2 cells (Figure 2C). At E14.5,
TROP2 expression was up-regulated, resulting in a broad
distribution of TROP2 expression from TROP2
low to TROP2
high.
In addition, the EpCAM
+TROP2
2 cells increased during
development, which is consistent with the results of immunostain-
ing. These results suggested that the expression profiles of EpCAM
and TROP2 define the distinct cell types in the developing urinary
duct. To characterize E14.5 kidney cells, EpCAM
+ cells were
fractionated into three populations by cell sorting, EpCAM
+-
TROP2
2, EpCAM
+TROP2
low and EpCAM
+TROP2
high cells,
based on the expression levels of TROP2 (Figure 2D).
The tip and trunk cells of the ureteric bud can be distinguished
by the expression of specific markers. Quantitative RT-PCR
revealed that Ret, Wnt11 and GFRa, tip cell markers [21–24],
were highly expressed in EpCAM
+TROP2
low cells, whereas
Wnt9b, a trunk cell marker [25], was strongly expressed in
EpCAM
+TROP2
high cells (Figure 2E). These results indicate that
the EpCAM
+TROP2
low and EpCAM
+TROP2
high populations
include the tip and trunk cells, respectively, and that ureteric bud
cells at different locations can be isolated by cell sorting based on
TROP2 expression. It has been reported that EpCAM is
expressed in the ureteric bud and also in the tissue derived from
the metanephric mesenchyme by the mesenchymal-epithelial
transition (MET) [20]. We found that EpCAM
+TROP2
2 cells
expressed Sall1, a marker of metanephric mesenchymal cells
[26](Figure 2E), and that the number of EpCAM
+TROP2
2 cells
increased from E12.5 to E14.5, corresponding to the timing of
MET [27](Figure 2C). These results suggest that the EpCAM
+-
TROP2
2 population is mainly composed of epithelial cells derived
from the metanephric mesenchyme.
Expression of TROP2 in ureteric buds
TROP2 is highly expressed in a variety of carcinomas and
involved in cancer cell proliferation [11,28]. In kidney develop-
ment, a previous study showed that cell proliferation is restricted
mainly to the tip of the ureteric bud in fetal kidney, which
corresponds to TROP2
low cells [17]. In fact, immunostaining of
Ki67, a marker of cell proliferation, showed the expression to be
higher in the tip cells than in the trunk cells (Figure S1). This result
suggests that, unlike in carcinomas, the TROP2 expression level is
not positively correlated with cell proliferation in fetal kidney.
Furthermore, in the corneal epithelia, TROP2 enhances the
expression and localization of tight junctional proteins, including
Claudin-1 and Claudin-7 [12]. However, immunostaining showed
that in contrast to the gradient of TROP2 expression, Claudin-7
was uniformly expressed throughout the ureteric bud cells (Figure
S2A). Moreover, Claudin-7 was found only in the lateral
membrane of the ureteric duct, while TROP2 was located in
both the lateral and basal membranes (Figure S2B). These results
indicate that expression of TROP2 and Claudin-7 are not fully
correlated in the fetal kidney, suggesting that TROP2 is not only
involved in the formation of tight junctions in the ureteric bud.
The ureteric bud is surrounded by collagen-I in fetal
kidney
The extracellular matrix (ECM) is important for the growth and
branching morphogenesis of embryonic organs [29]. In fetal
kidney, the ureteric bud and the collecting duct express low and
high levels of collagen-binding integrins a1 and a2, respectively,
suggesting collagen to play a role in the differentiation and
maturation of the ureteric bud by binding to integrins [30,31].
Because trunk cells in the ureteric bud differentiate to form the
collecting duct, we examined the expression of collagen and
TROP2 in the developing kidney by immunostaining. In E14.5
kidney, type I collagen (collagen-I) was abundant surrounding the
TROP2
+ trunks as well as in the mesenchyme and stroma around
the ureteric bud trunk (Figure 3A). By contrast, little collagen-I was
detected surrounding EpCAM
+ tip cells (Figure S3).
Integrins are major cell-surface receptors that mediate interac-
tions between cells and the ECM and play a crucial role in various
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anti-apoptosis [32,33]. Integrins consist of a and b subunits, with
the extracellular domain of the a subunit conferring their
specificity. To compare the expression of collagen-binding
integrins such as integrin a1b1 and integrin a2b1 between the
trunk and tip cells in the ureteric bud, we performed a quantitative
RT-PCR analysis of integrins using the sorted EpCAM
+TRO-
P2
low and EpCAM
+TROP2
high cells from E14.5 kidney
(Figure 3B). There was no significant difference in the levels of
collagen-binding integrin subunits, a1, a2 and b1 between the
trunk and tip cells, suggesting that the tip and trunk cells have a
similar potential to bind collagen via integrins. Considering the co-
localization of TROP2 and collagen-I at the basal membrane of
the ureteric bud, TROP2 may play a role in the development of
trunk cells such as branching by modulating the function of
collagen-I.
Tip and trunk cells exhibit different potential to attach to
and spread on collagen-I
To further characterize the collagen-binding properties of fetal
ureteric bud cells, sorted tip and trunk cells in the ureteric buds
were cultured on collagen-coated dishes. The numbers of cells
attached to collagen-coated dishes were smaller for EpCAM
+-
TROP2
high cells than EpCAM
+TROP2
low cells, indicating that
the trunk cells bind to collagen-I less efficiently (Figure 4A).
Furthermore, while forward and side scatter by flow cytometry
showed no significant difference in cell size between tip and trunk
cells before plating (data not shown), the EpCAM
+TROP2
low cells
were spread on the collagen-coated plates and exhibited
membrane ruffles, resulting in an increase in cell size compared
with the EpCAM
+TROP2
high trunk cells (Figure 4 B, C). It is
known that new branches emerge from the tip and trunk cells form
the mature ducts during the formation of ureteric bud branches,
suggesting that the characteristics of tip and trunk cells in the same
branch are different. These findings indicate that our primary
cultures of ureteric bud cells recapitulate the differentiation process
in vivo, i.e., the tip cells spread and migrate into the metanephric
mesenchyme, whereas the differentiating trunk cells are less active.
Furthermore, although there was no difference in the expression
of collagen-binding integrins between the tip and trunk cells in the
ureteric bud, the potential of EpCAM
+TROP2
high trunk cells to
attach to and spread on collagen-coated plates was low, suggesting
that factors other than the integrins regulate the interaction
between trunk cells and collagen-I. Because TROP2 was
expressed at a higher level in the trunk than tip cells and co-
localized with collagen-I in the basal membrane of ureteric ducts,
TROP2 may affect the potential of trunk cells to adhere to
collagen-coated plates.
TROP2 expression suppresses cell spreading
To reveal the role of TROP2 in the cell spreading on collagen-I,
we sorted EpCAM
+TROP2
low cells and overexpressed TROP2 by
expression vector in the primary culture. Compared with the
control cells transfected with the empty vector, the size of cells
overexpressing TROP2 was markedly reduced, strongly suggesting
that TROP2 affects the potential of EpCAM
+TROP2
low tip cells
to spread on collagen-I (Figure 4D, E).
To further confirm the role of TROP2 in the formation of
ureteric bud branches, we utilized Madin-Darby canine kidney
(MDCK) cells [34], established as a model for studying the
Figure 1. Expression of TROP2 and EpCAM in mouse at E14.5. (A–C) Immunostaining of E14.5 mouse frozen sections with anti-EpCAM (green)
and anti-TROP2 (red) Abs. EpCAM was expressed in epithelial cells of various organs. By contrast, TROP2 expression was restricted to EpCAM
+ cells in
the kidney, gut and epidermis. L ; Lung, Lv ; Liver, P ; Pancreas, G ; Gut, K ; Kidney, Epi ; Epidermis, D ; Dermis, Scale bars=200 mm.
doi:10.1371/journal.pone.0028607.g001
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PLoS ONE | www.plosone.org 3 December 2011 | Volume 6 | Issue 12 | e28607Figure 2. Characteristics of ureteric bud cells in the developing kidney. (A–B) Immunostaining of E11.5 (A) and E14.5 (B) kidney with anti-
EpCAM (green) and anti-TROP2 (red) Abs and nuclei (blue). (A) Arrowheads indicate the Wolffian duct and the arrow indicates the ureteric bud.
Higher magnification images of the boxed regions are shown underneath. In the lower figure of A, the ureteric bud grows toward the bottom and
the yellow arrowhead indicates the tip of the ureteric bud. Scale bars=50 mm. (B) The dotted line delineates the periphery of the kidney. Scale
bars=100 mm. (C) Flow cytometry of E12.5 and E14.5 kidney cells using anti-EpCAM and anti-TROP2 Abs. The boxed regions and the dotted boxed
regions show TROP2
+ and TROP2
2 cell populations, respectively. (D) Fractionation of EpCAM+ cells in E14.5 kidney using anti-EpCAM and anti-TROP2
Abs. The upper, middle and lower boxed regions in the panel indicate the EpCAM
+TROP2
high, EpCAM
+TROP2
low and EpCAM
+TROP2
nega cell
population, respectively. (E) Quantitative RT-PCR analysis of marker genes in freshly isolated E14.5 EpCAM
+TROP2
nega(2), EpCAM
+TROP2
low(+) and
EpCAM
+TROP2
high(++) cells. The relative gene expression of marker/GAPDH is shown. Error bars are s.d.
doi:10.1371/journal.pone.0028607.g002
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TROP2 was detectable in MDCK cells by RT-PCR (Figure S4A),
we established MDCK cell lines stably expressing TROP2 using
retroviral vectors (Figure S4B and S4C).
To confirm the results obtained with the primary cultures of
ureteric bud cells, the effect of TROP2 expression on the
spreading of MDCK cells was examined. Cells detached from a
confluent monolayer were plated on a collagen-coated glass cover
slip and images were captured at 1 and 2.5 h after plating. Control
MDCK cells started to spread at least 30 min earlier than
MDCK-TROP2 cells (data not shown). At 2.5 h after plating,
approximately 50% of the control MDCK cells had spread
(Figure 5 A, B). By striking contrast, 70% of MDCK-TROP2 cells
retained a round shape without cytoplasmic extensions. This result
together with the results obtained using the primary cultures
indicates that the expression of TROP2 significantly suppressed
spreading of kidney cells.
MDCK cells displayed membrane ruffles with cortical actin
filaments and stress fibers when cultured on collagen-coated glass
cover slips, whereas TROP2 expression suppressed the membrane
ruffling and stress fibers (Figure 5C). Since membrane ruffling is
implicated in cell motility, we examined the effect of TROP2 on
cell motility with the wound healing assay. The gap in cell sheets
formed by a scratch was measured at 0 and 6 h. Expression of
TROP2 suppressed the migration of MDCK cells 6 h after the
scratch was made (Figure 5 D, E), suggesting that TROP2 also
plays a role in suppressing cell spreading and migration on
collagen.
TROP2 inhibits the branching of MDCK cells in collagen-
gel culture
As the spreading and migration of ureteric bud cells are
necessary for the development of renal tubules, we examined the
effect of TROP2 on tubulogenesis and branch morphogenesis
using MDCK cells in three-dimensional collagen-gel cultures.
There was no significant difference in cyst size between clusters of
control MDCK and MDCK-TROP2 cells in the collagen-gel
cultures (Figure 6A, the top panels). The addition of 20 ng/mL of
hepatocyte growth factor (HGF), a cell scattering factor, induced
morphological changes in control MDCK cells, forming branches
(Figure 6A, the left bottom panel). By contrast, MDCK-TROP2
cells formed round cysts without branching (Figure 6A, the right
Figure 3. Expression of collagen-I and integrins in the fetal kidney. (A) Immunostaining of E14.5 kidney with anti-TROP2 (green) and anti-
collagen-I (red) Abs and nuclei (blue). Higher magnification images of the boxed regions are shown underneath. Arrowheads indicate collagen-I
surrounding the ureteric trunks. Scale bars=100 mm. (B) Quantitative RT-PCR analysis of integrin subunits in freshly isolated EpCAM
+TROP2
low(+) and
EpCAM
+TROP2
high(++) cells from E14.5 kidney. The relative gene expression of integrin/GAPDH is shown. Error bars are s.d.
doi:10.1371/journal.pone.0028607.g003
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branching formation (Figure 6B). These results suggest that
TROP2 antagonizes the cell scattering activity of HGF during
branch formation. These results together reveal that TROP2
suppresses cell spreading and migration on collagen-I, suggesting
that it contributes to the complicated branching structures of the
kidney by suppressing the formation of branches from the ureteric
bud trunks.
Discussion
TROP2 and EpCAM are structurally related molecules,
however, their expression profiles differ significantly. In the
E14.5 fetus, EpCAM is widely expressed in various epithelial
tissues, whereas TROP2 expression is restricted to some epithelial
cells in the kidney, lung and epidermis (Figure 1). During the
branching morphogenesis of ureteric buds, new branches emerge
from the tip through the proliferation and migration of tip cells.
Meanwhile, the trunk elongates to form a rigid structure like a
stalk without branching. TROP2 expression shows a gradient,
increasing from the tip to trunk, suggesting that TROP2
contributes to the trunk structure (Figure 2).
ECM components play fundamental roles in the branching
morphogenesis of the ureteric bud, exerting their functions
through ECM-specific integrin receptors. Mice deficient in a3-
integrin, a laminin-binding integrin subunit, fail to form branches
of ureteric buds from the Wolffian duct, indicating laminin to be
an important ECM component for branching morphogenesis [16].
On the other hand, the function of collagen-I in fetal kidney
remains unknown, because mice deficient in either a1o ra2
Figure 4. Characterization of ureteric tip and trunk cells in vitro. (A) Attachment of tip and trunk cells to collagen-coated plates. An equal
number (5610
3 cells/well) of freshly isolated EpCAM
+TROP2
low and EpCAM
+TROP2
high cells from E14.5 kidney were plated on a collagen-coated 96-
well plate and stained for actin filaments with Alexa488-conjugated phalloidin (green) after 24 h of culture. The fluorescence of GFP and the actin
filaments was visualized under a microscope. Nuclei (blue). Scale bars=100 mm. (B) Cell morphology of ureteric bud tip and trunk cells. Higher-
magnification images of (A) are shown. Arrowheads indicate the ruffles forming at the edge of membranes. Scale bars=50 mm. (C) Spreading of
EpCAM
+TROP2
low(+) and EpCAM
+TROP2
high(++) cells. Cell size was measured using imageJ (n=3). Error bars are s.d., * p,0.005. (D) Cell morphology
of EpCAM
+TROP2
low cells after enforced expression of TROP2. EpCAM
+TROP2
low cells cultured for 24 h were transiently transfected with pTIB741 or
pTIB741-TROP2 plasmid. At 24 hours after transfection, cells were stained with Alexa555-phalloidin (red). Arrowheads indicate the transfected cells
expressing GFP. (E) The ratio of spreading in transfected cells. The cell of which diameter is more than two-fold of nuclear is counted as ‘‘spreading
cell’’. All the experiments were repeated three times and the similar results were obtained. Total number of tested transfectants is as follows: Control;
66, TROP2; 94. Representative results are shown.
doi:10.1371/journal.pone.0028607.g004
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the branching of ureteric buds [35,36]. However, collagen-gel
cultures of MDCK cells show that integrin a1 and a2 are essential
for generating new branches and tubular structures [30,37]. We
have demonstrated here that collagen-I is present around the
ureteric bud and there is a gradient of its expression from the tip to
trunk during branching (Figure 3 and Figure S3). These results
together suggest that collagen-I plays an important role in
branching morphogenesis in fetal kidney.
An important finding of this study is the restricted expression
and co-localization of TROP2 and collagen-I at the trunk of the
ureteric duct. In contrast to collagen-I, where expression is
restricted to that region, laminin is expressed almost uniformly
around the ureteric bud (Figure S5). These expression patterns
suggest a functional link between TROP2 and collagen-I. In fact,
TROP2
high trunk cells showed reduced adhesion and spreading on
collagen-I-coated plates compared to TROP2
low tip cells, though
levels of collagen-binding integrin receptors a1, a2 and b1 were
comparable between the trunks and tips (Figure 3B). To reveal the
role in TROP2 for the binding and spreading of ureteric bud cells
on collagen-I, we overexpressed TROP2 in TROP2
low tip cells
and found the binding and spreading to be reduced. We also
demonstrated that TROP2 expression inhibits the spreading and
migration of MDCK cells on collagen-I.
Figure 5. Attachment and migration of MDCK cells. (A) Cell spreading assay. Equal numbers of MDCK-control cells and MDCK-TROP2 cells,
which expressed GFP and TROP2, respectively, were plated on collagen-coated glass coverslips. At 1 and 2.5 h after plating, spreading cells in several
random fields were counted under a phase-contrast microscope. Arrowheads indicate spreading cells. Scale bars=100 mm. (B) The percentage of
spreading cells (n=200). (C) MDCK-control cells and MDCK-TROP2 cells were plated on collagen-coated glass coverslips for 24 h and stained with
Alexa555-Phalloidin. Arrowheads indicate the membrane ruffling at the edge of cells. Scale bars=50 mm. (D) Wound healing assay. Cells grown as a
monolayer on collagen-gel were scratched with a pipette tip. Photomicrographs were taken at 0, 6 and 16 h to record the healing process.
Representative images are shown. An arrowhead indicates the unrecovered area. Scale bars=100 mm. (E) The average migratory distance at 6 h after
the scratch was measured manually (n=3). Error bars, s.d. * p,0.05, ** p,0.01.
doi:10.1371/journal.pone.0028607.g005
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also growth factor signaling. In collagen-gel cultures of MDCK cells,
a well-established model of branch formation, growth factors such as
HGF and GDNF are necessary for branching [18,38]. Studies with
fetal kidney organ cultures and knockout mice have revealed the
essential roles for many growth factors in branching morphogenesis.
In response to growth factors, tip cells proliferate, migrate and finally
form new branches, whereas trunk cells exhibit cell polarization,
elongation and anti-apoptotic activity without branching [39–41]. In
this paper we showed that TROP2 inhibits not only the attachment
of cells onto collagen-coated plates but also branching in collagen-gel
cultures. These results strongly suggest that TROP2 suppresses the
formation of new branches at the trunk of the ureteric bud.
Focal adhesion kinase (Fak) is phosphorylated by the activation of
integrins through binding to ECM and also growth factor
stimulation [42]. p-Fak promotes cell extension and migration
through actin polymerization and the connection of F-actin to
integrin and growth factor receptors at the edge of cells, contributing
to branching. In cell spreading assays, the phosphorylation level of
Fak in MDCK-TROP2 cells was declined (Figure S6A), suggesting
that TROP2 may inhibit the Fak signaling pathway at the ureteric
trunk to avoid extra branching. While immunostaining showed that
p-FAK levels are comparable in the tip and trunk cells (Figure S6B),
it may be difficult to capture the transient event in static sections.
TROP2 and EpCAM are expressed in normal epithelial tissues,
while they are known as oncogene and promote cancer cell
proliferation and migration. EpCAM up-regulates cell motility by
binding to several membrane proteins, Claudins, CD44 and
tetraspanins, and a-actinin, a linker of F-actins [8,43]. Furthermore,
in cancer cells, intracellular domain of EpCAM cleaved by TACE
and presenilin-2 accelerates cell proliferation through the activation
of b-catenin signaling [9]. By contrast, the molecular mechanisms of
TROP2 in normal and cancer tissue are not known. Immunopre-
cipitation assays showed that TROP2 binds EpCAM (data not
shown),suggesting the possibility that TROP2interacts with EpCAM
and regulates the cell proliferation and migration activity. In ureteric
bud development, TROP2 expression shows a gradient pattern in
contrast to uniform expression of EpCAM. Furthermore, the
TROP2 expression declines toward tip where cells are actively
proliferating and migrating, suggesting that TROP2 is involved in
regulation of cell proliferation, possibly via interaction with other
proteins like EpCAM. Thus, the difference in expression profiles of
TROP2-interacting proteins between normal and cancer cells may
modulate the function of TROP2. The precise role of the TROP2 in
normal and cancer tissue needs further investigation.
In the lung, which also has a tree-like structure, branching
morphogenesis is induced by the interaction between mesenchyme
and epithelial cells, similar to the ureteric bud [44]. However,
TROP2 is not expressed in the lung (Figure 1A) and the branching
pattern is clearly different from the ureteric buds in the early
stages. Lung epithelial cells generate several lateral branches from
trunks. By contrast, the ureteric bud generates two epithelial tips
after the first branching and repeats this dichotomous branching
process, and trunks form a rigid duct structure by establishing tight
cell-cell junctions and suppressing the formation of new branches
[45]. Specific expression of TROP2 in the kidney may result in the
difference in branching patterns between the lung and kidney.
In conclusion, this study revealed a unique pattern of TROP2
expression in the ureteric bud, i.e., the expression was strongest in
the trunk and gradually declined toward the tip. TROP2 and
collagen-I were co-localized to the basal membrane of the trunk cells
and TROP2 suppressed cell spreading and migration on collagen-I.
Based on these findings, we propose that TROP2 plays a role in the
morphogenesis of the ureteric bud by inhibiting unnecessary
branching from the trunk. Further studies on the function of
TROP2 forming a specific pattern of tubular structures should shed
light on the molecular basis of branching in various organs.
Materials and Methods
Ethics Statement
The mice were maintained and mated in the institutional animal
facility according to the guidelines of the University of Tokyo. The
experimental procedures in this study were approved by the Animal
Research Committee of the Institute of Molecular and Cellular
Biosciences, the University of Tokyo (approval number is 23003).
Immunohistochemistry
Mouse embryonic kidneys were fixed for 16 h at 4uCi n
Zamboni’s solution [46], which was replaced with a 10, 15 and
Figure 6. Branch formation in collagen-gel culture of MDCK cells. (A) Phase-contrast images of MDCK-control cells and MDCK-TROP2 cells
cultured in 3-dimensional collagen gels. The cells were cultured without (upper panels) or with 20 ng/mL of HGF (lower panels). Both cells
proliferated and formed round cysts without HGF (upper panels). Branches were formed in MDCK-control cells but suppressed in MDCK-TROP2 cells
(lower panels). Scale bars=100 mm. (B) The percentage of branching cysts in the culture with HGF. (n=3). Error bars, s.d. * p,0.05.
doi:10.1371/journal.pone.0028607.g006
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were embedded in OCT compound and frozen. Thin sections
were prepared with a cryostat (Leica). Cultured ureteric bud cells
and MDCK cells were fixed in 4% PFA for 10min. Samples were
incubated with the primary antibodies listed in Table S1. Signals
were visualized with Alexa Fluor-conjugated secondary antibodies
(Molecular Probes) used at a dilution of 1:500. F-actin bundles
were detected with Alexa Fluor 488- or 555-conjugated phalloidin
(Molecular Probes) at a dilution of 1:250. Nuclei were counter-
stained with Hoechst 33342 (Sigma).
Flow cytometric analysis and cell sorting
Kidneys isolated from embryos were incubated with 0.25%
trypsin and 0.5mM EDTA at 37uC for 30min and dissociated into
a single-cell suspension. Cells were co-stained with fluorescein- and
biotin-conjugated antibodies, washed, incubated with allophyco-
cyanin-conjugated streptavidin (Invitrogen), and analyzed by
FACSCalibur (Becton Dickinson). Dead cells were excluded by
propidium iodide staining. For cell sorting, MoFlo XDP (Beckman
Coulter) was used.
RNA extraction and quantitative reverse transcription
PCR (RT-PCR)
Total RNA was extractedfrom each cell preparation using a First
Pure RNA kit (Takara). Total RNA (0.3 mg) and random hexamer
primers were used to synthesize cDNA with a High Capacity cDNA
Reverse Transcription Kit (Applied Biosystems). Quantitative Real-
time RT-PCR experiments were conducted with a LightCycler
(Roche Diagnostics) and SYBR Premix Ex Taq (Takara-bio).
Primers for Glyceraldehyde-3-phosphate dehydrogenase (Gapdh)
were used as the control. The pairs of primers used were as follows:
59-TGAACGGGAAGTCACTGG-39 (Gapdh primer, sense), 59-
TCCACCACCCTGTTGCTGTA-39 (Gapdh primer, antisense),
59-CTGACCTAGACTCCGAGCTG-39 (TROP2 primer, sense),
59-CGGCCCATGAACAGTGACTC-39 (TROP2 primer, anti-
sense), 59-AGGGGCGATCCAGAACAACG-39 (EpCAM primer,
sense), 59-ATGGTCGTAGGGGCTTTCT-39 (EpCAM primer,
antisense), 59-AAGTACAGCACCAAGTTCCTCAGC-39 (Wnt9b
primer, sense), 59-GAACAGCACAGGAGCCTGACAC-39
(Wnt9b primer, antisense), 59-CTGAATCAGACGCAACACTG-
TAAAC-39 (Wnt11 primer, sense), 59-CTCTCTCCAGGTCAAG-
CAGGTAG-39 (Wnt11 primer, antisense), 59-GGAAGGT-
GTCGTTGATGAAGGA-39 (Ret primer, sense), 59-CTCAGCA-
TCCGCAATGGTG-39 (Ret primer, antisense), 59-CACTCCTG-
GATTTGCTGATGT-39 (GFRa primer, sense), 59-CTGAAG-
TTGGTTTCCTTGCCC-39 (GFRa primer, antisense), 59-CCC-
GATGACCAAATGAAAGACG-39 (Sall1 primer, sense), 59-TA-
GAGAGGTTGTGATCGCTGA-39 (Sall1 primer, antisense).
Culture of ureteric bud cells and transfections
Ureteric bud cells from E14.5 kidneys were suspended in
DMEM/F12 (1:1) medium (Gibco) containing 10% FBS (JRH)
and antibiotics. Cells were seeded on type-I collagen-coated dishes.
Relative cell size was measured as the actin-positive area using
ImageJ (Rasband, W.S., NIH) and cellular area was determined.
To express mouse TROP2, its cDNA fragment was inserted
upstream of IRES-GFP in the vector pTIB731, provided by Dr.
Tohru Itoh (University of Tokyo). Ureteric bud cells were sorted
and cultured for 24 h prior to transfection. The transfection was
carried out using polyethyleneimine ‘‘Max’’ reagent (Polysciences
Inc.). Twenty four hours later, the cells were immunostained and
the size of the GFP
+ transfected cells was examined under a
fluorescence microscope.
MDCK cell culture and virus infection
MDCK cells were cultured in DMEM (Gibco) containing 10%
FBS (Equitech) and antibiotics [34]. For expression of mouse
TROP2, its cDNA was inserted into the pMxs vector. The pMxs-
IRES-GFP vector was used as a negative control. Retrovirus was
produced using the retrovirus packaging cell line PLAT-A and
MDCK cells were infected as described previously [47]. Cells
expressing TROP2 or GFP were sorted using anti-TROP2 Abs or
GFP and MDCK cells expressing GFP (MDCK-control) or
TROP2 (MDCK-TROP2) were established.
Immunoblotting
MDCK cells were lysed in TNE buffer (20 mM Tris-HCl,
pH 7.4, 150 mM NaCl, 2 mM EDTA, 1% Nonidet P-40, 1 mM
phenylmethylsulfonyl fluoride, 1 mM Pefabloc SC (Roche Applied
Science), and 10 mg/ml leupeptin), and the whole cell extracts
were separated by SDS-PAGE and transferred onto polyvinyli-
dene difluoride membranes (Immobilon-P; Millipore). The
membranes were subjected to Western blot analyses with anti-
TROP2, anti-Fak or anti-p-Fak (Tyr397) antibody. Anti-b-actin
antibody was used to confirm equal loadings.
Cell spreading assay
MDCK cells were detached by trypsin and resuspended in
serum-free medium at 5610
3 cells/ml. The cell suspension (1 ml)
was added to type I collagen-coated coverslips. Cells were allowed
to spread, and spread cells were scored manually under a phase-
contrast microscope at 1 and 2.5 h after plating. Spread cells were
defined as the cells with extended processes.
Wound healing assay
MDCK cells were grown on collagen-coated 60 mm dishes.
The monolayer of cells was scratched with a pipette tip and the
culture medium was changed to serum-free medium. Pictures were
taken at 0, 6 and 16 h and the length of the gap between cell sheets
was measured at 0 and 6 h.
Collagen gel culture
MDCK cells were detached from plates with trypsin and
triturated into a single cell suspension. Cells were diluted to
0.5610
3 cells/mL in a type I collagen solution and the cell solution
was plated in a 24-well plate (500 mL/well). After incubation at
37uC to allow the collagen solution to gel, 1 mL of the culture
medium was added. The medium was changed every 24 h, and
after 2 days, medium containing 20 ng/mL of HGF was added
and cultured for additional 2 days.
Supporting Information
Figure S1 Expression of TROP2 and Ki67 in E14.5 kidney.
(TIF)
Figure S2 Expression of Claudin7 and TROP2 in E14.5
kidney.
(TIF)
Figure S3 Expression of collagen-I and EpCAM in E14.5
kidney.
(TIF)
Figure S4 Establishment of MDCK cells expressing
TROP2.
(TIF)
Figure S5 Expression of laminin in E14.5 kidney.
(TIF)
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the ureteric bud.
(TIF)
Table S1 Primary antibodies used in immunofluores-
cence chemistry and flow cytometric analysis.
(TIF)
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